<p>India's Dr Reddy's Laboratories Ltd will seek emergency-use authorisation for Russia's Sputnik V coronavirus vaccine by next month, a company official said on Wednesday, after peer-reviewed trial data confirmed its effectiveness.</p>.<p>A source close to the drug regulator said the application could come within days and when approved, bolster India's 18-day-old immunisation campaign which has covered more than 4 million people with two other shots.</p>.<p>Dr Reddy's has been working with the Russian Direct Investment Fund (RDIF) to hold small clinical trials of Sputnik V in India. On Tuesday, RDIF told Indian news agency ANI that it expected to get approval for the vaccine this month or the next.</p>.<p><a href="https://www.deccanherald.com/tag/coronavirus-vaccine" target="_blank"><strong>Follow latest updates on the coronavirus vaccine here</strong></a></p>.<p>"We will be applying for emergency-use authorisation (EUA) by March 2021," a Dr Reddy's spokeswoman told Reuters in an email, adding that the company had partnered with RDIF to distribute 250 million doses.</p>.<p>Indian regulator the Central Drugs Standard Control Organisation (CDSCO) had no immediate comment on a potential application.</p>.<p>The vaccine has proved 91.6% effective against Covid-19, based on late-stage trials in Russia, results published in the Lancet medical journal showed on Tuesday.</p>.<p>More than a million people in Russia have received Sputnik V, which is marketed abroad by the RDIF and has been approved for emergency use in Algeria, Argentina, Bolivia, Mexico and Serbia.</p>.<p>RDIF expects India, the world's biggest vaccine maker, to produce about 300 million doses of Sputnik V this year. Hetero Biopharma is making more than 100 million doses.</p>.<p>India's regulator has approved for emergency use the AstraZeneca vaccine and another developed at home by Bharat Biotech and the state-run Indian Council of Medical Research.</p>.<p>A similar request from Pfizer and partner BioNTech for their vaccine is pending with the regulator.</p>.<p>India says it is the nation fastest to reach the milestone of 4 million vaccinations, with the United States taking 18 days and Israel and Britain 39 days each. Reuters could not find comparable data for China.</p>.<p>Except for the United States, India has the most virus infections, reporting 11,039 new cases on Wednesday, taking its tally to 10.78 million. Deaths rose 110 to stand at 154,596.</p>
<p>India's Dr Reddy's Laboratories Ltd will seek emergency-use authorisation for Russia's Sputnik V coronavirus vaccine by next month, a company official said on Wednesday, after peer-reviewed trial data confirmed its effectiveness.</p>.<p>A source close to the drug regulator said the application could come within days and when approved, bolster India's 18-day-old immunisation campaign which has covered more than 4 million people with two other shots.</p>.<p>Dr Reddy's has been working with the Russian Direct Investment Fund (RDIF) to hold small clinical trials of Sputnik V in India. On Tuesday, RDIF told Indian news agency ANI that it expected to get approval for the vaccine this month or the next.</p>.<p><a href="https://www.deccanherald.com/tag/coronavirus-vaccine" target="_blank"><strong>Follow latest updates on the coronavirus vaccine here</strong></a></p>.<p>"We will be applying for emergency-use authorisation (EUA) by March 2021," a Dr Reddy's spokeswoman told Reuters in an email, adding that the company had partnered with RDIF to distribute 250 million doses.</p>.<p>Indian regulator the Central Drugs Standard Control Organisation (CDSCO) had no immediate comment on a potential application.</p>.<p>The vaccine has proved 91.6% effective against Covid-19, based on late-stage trials in Russia, results published in the Lancet medical journal showed on Tuesday.</p>.<p>More than a million people in Russia have received Sputnik V, which is marketed abroad by the RDIF and has been approved for emergency use in Algeria, Argentina, Bolivia, Mexico and Serbia.</p>.<p>RDIF expects India, the world's biggest vaccine maker, to produce about 300 million doses of Sputnik V this year. Hetero Biopharma is making more than 100 million doses.</p>.<p>India's regulator has approved for emergency use the AstraZeneca vaccine and another developed at home by Bharat Biotech and the state-run Indian Council of Medical Research.</p>.<p>A similar request from Pfizer and partner BioNTech for their vaccine is pending with the regulator.</p>.<p>India says it is the nation fastest to reach the milestone of 4 million vaccinations, with the United States taking 18 days and Israel and Britain 39 days each. Reuters could not find comparable data for China.</p>.<p>Except for the United States, India has the most virus infections, reporting 11,039 new cases on Wednesday, taking its tally to 10.78 million. Deaths rose 110 to stand at 154,596.</p>